Professional Summary »
Practice Locations »
Referring Physicians »
Biography
Dr. Anubodh Sunny Varshney is a Clinical Assistant Professor in the section of Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford. In addition to caring for patients with advanced heart disease, he is also an Investigator in the Cardiovascular Outcomes, Policy, & Implementation Research Group (https://www.copirgroup.com/) where he works to identify patient groups that have ongoing unmet medical needs, define benchmark outcomes that next generation therapies should improve upon, and understand factors that influence clinical adoption of novel drug and device therapies.
Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.
Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke.
Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.
Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke.
View Full Biography »
Professional Summary
Education & Certifications
- Fellowship, Stanford University, Advanced Heart Failure and Transplant Cardiology (2023)
- Fellowship, Brigham and Women's Hospital / Harvard Medical School, Cardiovascular Medicine (2022)
- Residency, Brigham and Women's Hospital / Harvard Medical School, Internal Medicine (2017)
- MD, University of Texas Southwestern Medical School (2014)
- BS, Washington University in St. Louis, Biomedical Engineering (2010)
- Board Certification: American Board of Internal Medicine, Cardiovascular Disease (2021)
- Board Certification: American Board of Internal Medicine, Internal Medicine (2017)
Honors & Awards
- Charles L. Feldman, Sc.D. Research Scholar Award, Brigham and Women’s Hospital Vascular Profiling Laboratory (2018)
- Hemphill-Gojer Award in Internal Medicine, University of Texas Southwestern Medical School (2014)
- Martin P. Solomon Primary Care Scholarship Award, Brigham and Women’s Hospital Department of Medicine (2016)
- Resident Mentor Award, Brigham and Women’s Hospital Department of Medicine (2017)
- Young Investigator Award in Heart Failure Runner Up, European Society of Cardiology (2023)
Memberships
- Advisor, Broadview Ventures (2017 - Present)
- Advisor, Texas Health Catalyst at UT Austin Dell Medical School (2021 - Present)
Publications
-
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes.
Varshney, A. S., Berg, D. D., Katz, J. N., Baird-Zars, V. M., Bohula, E. A., Carnicelli, A. P., … Morrow, D. A. (2020). Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. JAMA Cardiology. -
Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.
Bhatt, A. S., Varshney, A. S., Goodrich, E. L., Gong, J., Ginder, C., Senman, B. C., … Bohula, E. A. (2022). Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry. Journal of the American Heart Association, 11(9), e024451. -
Increased Opportunities for Transplantation for Women in the New Heart Allocation System.
Defilippis, E. M., Truby, L. K., Clerkin, K. J., Donald, E., Sinnenberg, L., Varshney, A. S., … Farr, M. (2022). Increased Opportunities for Transplantation for Women in the New Heart Allocation System. Journal of Cardiac Failure, 28(7), 1149–1157. -
Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar.
Varshney, A. S., DeFilippis, E. M., Cowger, J. A., Netuka, I., Pinney, S. P., & Givertz, M. M. (2022). Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar. Journal of the American College of Cardiology, 79(11), 1092–1107. -
The Enabling Potential of Device Therapy for Heart Failure.
Varshney, A. S., Butler, J., & Vaduganathan, M. (2022). The Enabling Potential of Device Therapy for Heart Failure. Journal of Cardiac Failure, 28(7), 1227–1229. -
A Heart Team approach to contemporary device decision-making in heart failure.
Varshney, A. S., Singh, J. P., & Vaduganathan, M. (2022). A Heart Team approach to contemporary device decision-making in heart failure. European Journal of Heart Failure, 24(3), 562–564. -
Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network.
Berg, D. D., Alviar, C. L., Bhatt, A. S., Baird-Zars, V. M., Barnett, C. F., Daniels, L. B., … Bohula, E. A. (2022). Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network. Journal of Cardiac Failure, 28(4), 675–681. -
Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes.
Weber, B., Siddiqi, H., Zhou, G., Vieira, J., Kim, A., Rutherford, H., … Woolley, A. E. (2022). Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes. Journal of the American Heart Association, 11(1), e022010. -
Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.
Varshney, A. S., Omar, W. A., Goodrich, E. L., Bhatt, A. S., Wolley, A. E., Gong, J., … Bohula, E. A. (2021). Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. Heart Failure, 14(12), e008477. -
Hospitalization of Patients With (But Not for) Heart Failure: An Opportunity for Accelerated Guideline-Directed Medical Therapy Optimization?
Varshney, A. S., Bhatt, A. S., & Vaduganathan, M. (2021). Hospitalization of Patients With (But Not for) Heart Failure: An Opportunity for Accelerated Guideline-Directed Medical Therapy Optimization? Journal of Cardiac Failure, 27(8), 910–912. -
Contemporary Burden of Primary Versus Secondary Heart Failure Hospitalizations in the United States.
Varshney, A. S., Minhas, A. M., Bhatt, A. S., Ambrosy, A. P., Fudim, M., & Vaduganathan, M. (2021). Contemporary Burden of Primary Versus Secondary Heart Failure Hospitalizations in the United States. The American Journal of Cardiology, 156, 140–142. -
Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.
Bhatt, A. S., Varshney, A. S., Nekoui, M., Moscone, A., Cunningham, J. W., Jering, K. S., … Vaduganathan, M. (2021). Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study. European Journal of Heart Failure, 23(7), 1191–1201. -
Spatial relationships among hemodynamic, anatomic, and biochemical plaque characteristics in patients with coronary artery disease.
Varshney, A. S., Coskun, A. U., Siasos, G., Maynard, C. C., Pu, Z., Croce, K. J., … Stone, P. H. (2021). Spatial relationships among hemodynamic, anatomic, and biochemical plaque characteristics in patients with coronary artery disease. Atherosclerosis, 320, 98–104. -
Residual SYNTAX Score After Revascularization in Cardiogenic Shock: When Is Complete Complete?
Kochar, A., Varshney, A. S., & Wang, D. E. (2021). Residual SYNTAX Score After Revascularization in Cardiogenic Shock: When Is Complete Complete? Journal of the American College of Cardiology, 77(2), 156–158. -
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
Varshney, A. S., Wang, D. E., Bhatt, A. S., Blood, A., Sharkawi, M. A., Siddiqi, H. K., … Kochar, A. (2021). Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis. American Heart Journal, 232, 105–115. -
Recurrent bioprosthetic mitral valve thrombosis treated with anticoagulation.
Fernandes, R., Varshney, A. S., & Aragam, J. (2020). Recurrent bioprosthetic mitral valve thrombosis treated with anticoagulation. Echocardiography (Mount Kisco, N.Y.), 37(12), 2134–2138. -
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study.
Schrage, B., Becher, P. M., Bernhardt, A., Bezerra, H., Blankenberg, S., Brunner, S., … Westermann, D. (2020). Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study. Circulation, 142(22), 2095–2106. -
Outcomes in the 2018 UNOS donor heart allocation system: A perspective on disparate analyses.
Varshney, A. S., Hirji, S. A., & Givertz, M. M. (2020). Outcomes in the 2018 UNOS donor heart allocation system: A perspective on disparate analyses. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation, 39(11), 1191–1194. -
The Early Bird Catches the Worm: Should Severe LVH Be an Indication for Early TAVR?
Bhatt, D. L., & Varshney, A. S. (2020). The Early Bird Catches the Worm: Should Severe LVH Be an Indication for Early TAVR? JACC. Cardiovascular Interventions, 13(11), 1340–1342. -
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic.
Bhatt, A. S., Moscone, A., McElrath, E. E., Varshney, A. S., Claggett, B. L., Bhatt, D. L., … Vaduganathan, M. (2020). Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic. Journal of the American College of Cardiology, 76(3), 280–288. -
A Heart Murmur Is Discovered on an Oncology Ward: Extramedullary Acute Myeloid Leukemia.
Abboud, A., Zamalloa, J. R., Sellars, M., Garza-Mayers, A. C., Varshney, A. S., Osborne, M. T., … DeFilipp, Z. (2020). A Heart Murmur Is Discovered on an Oncology Ward: Extramedullary Acute Myeloid Leukemia. The American Journal of Medicine, 133(9), e457–e459. -
Watching for Disease: the Changing Paradigm of Disease Screening in the Age of Consumer Health Devices.
Varshney, A. S., Madias, C., Kakkar, R., & Martin, D. T. (2020). Watching for Disease: the Changing Paradigm of Disease Screening in the Age of Consumer Health Devices. Journal of General Internal Medicine, 35(7), 2173–2175. -
Risk stratification of coronary plaques using physiologic characteristics by CCTA: Focus on shear stress.
Samady, H., Molony, D. S., Coskun, A. U., Varshney, A. S., De Bruyne, B., & Stone, P. H. (2019). Risk stratification of coronary plaques using physiologic characteristics by CCTA: Focus on shear stress. Journal of Cardiovascular Computed Tomography, 14(5), 386–393. -
Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support.
Almarzooq, Z. I., Varshney, A. S., Vaduganathan, M., Pareek, M., Stewart, G. C., Estep, J. D., & Mehra, M. R. (2020). Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support. JACC. Cardiovascular Imaging, 13(4), 1069–1081. -
Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
Varshney, A. S., Manandhar, P., Vemulapalli, S., Kirtane, A. J., Mathew, V., Shah, B., … Bhatt, D. L. (2019). Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC. Cardiovascular Interventions, 12(4), 373–382. -
Role of local coronary blood flow patterns and shear stress on the development of microvascular and epicardial endothelial dysfunction and coronary plaque.
Siasos, G., Tsigkou, V., Zaromytidou, M., Sara, J. D., Varshney, A., Coskun, A. U., … Stone, P. H. (2018). Role of local coronary blood flow patterns and shear stress on the development of microvascular and epicardial endothelial dysfunction and coronary plaque. Current Opinion in Cardiology, 33(6), 638–644. -
What was old is new again: learning from the modern master clinician.
Varshney, A., Braun, D. A., Patel, A. B., & Yialamas, M. A. (2019). What was old is new again: learning from the modern master clinician. The Clinical Teacher, 16(3), 274–276. -
Impact of Antithrombotic Regimen on Mortality, Ischemic, and Bleeding Outcomes after Transcatheter Aortic Valve Replacement.
Varshney, A., Watson, R. A., Noll, A., Im, K. A., Rossi, J., Shah, P., & Giugliano, R. P. (2018). Impact of Antithrombotic Regimen on Mortality, Ischemic, and Bleeding Outcomes after Transcatheter Aortic Valve Replacement. Cardiology and Therapy, 7(1), 71–77. -
The Simplest Explanation: Pancytopenia.
Varshney, A., & Barkoudah, E. (2018). The Simplest Explanation: Pancytopenia. The American Journal of Medicine, 131(9), 1052–1054. -
Examining the applicability of SPRINT in patients with subclinical or established atherothrombotic disease: A REACH registry analysis.
Varshney, A., Steg, P. G., Elbez, Y., Sorbets, E., Eagle, K. A., & Bhatt, D. L. (2017). Examining the applicability of SPRINT in patients with subclinical or established atherothrombotic disease: A REACH registry analysis. International Journal of Cardiology, 243, 95–97. -
Biological Mesh Implants for Abdominal Hernia Repair: US Food and Drug Administration Approval Process and Systematic Review of Its Efficacy.
Huerta, S., Varshney, A., Patel, P. M., Mayo, H. G., & Livingston, E. H. (2016). Biological Mesh Implants for Abdominal Hernia Repair: US Food and Drug Administration Approval Process and Systematic Review of Its Efficacy. JAMA Surgery, 151(4), 374–81. -
Bridging Strategies and Cardiac Replacement Outcomes in Patients with Acute Decompensated Heart Failure-Related Cardiogenic Shock.
Varshney, A. S., Berg, D. D., Zhou, G., Sinnenberg, L., Hirji, S., DeFilippis, E. M., … Givertz, M. M. (2023). Bridging Strategies and Cardiac Replacement Outcomes in Patients with Acute Decompensated Heart Failure-Related Cardiogenic Shock. European Journal of Heart Failure. -
Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters.
Tang, M., Holmgren, A. J., McElrath, E. E., Bhatt, A. S., Varshney, A. S., Lee, S. G., … Huckman, R. S. (2022). Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters. JACC Advances, 1(5), 100156. -
Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy.
Schrage, B., Sundermeyer, J., Blankenberg, S., Colson, P., Eckner, D., Eden, M., … Westermann, D. (2022). Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy. JACC. Heart Failure. -
Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in Patients with Heart Failure: The IMPLEMENT-HF Study.
Bhatt, A. S., Varshney, A. S., Moscone, A., Claggett, B. L., Miao, Z. M., Chatur, S., … Vaduganathan, M. (2023). Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in Patients with Heart Failure: The IMPLEMENT-HF Study. Journal of the American College of Cardiology. -
Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
Varshney, A. S., Shah, M., Vemulapalli, S., Kosinski, A., Bhatt, A. S., Sandhu, A. T., … Vaduganathan, M. (2023). Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry. European Heart Journal. -
Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study.
Beer, B. N., Kellner, C., Goßling, A., Sundermeyer, J., Besch, L., Dettling, A., … Schrage, B. (2023). Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study. European Heart Journal. Acute Cardiovascular Care. -
Uptake of sodium-glucose cotransporter-2 inhibitors in hospitalized patients with heart failure: insights from the veterans affairs healthcare system.
Varshney, A. S., Calma, J., Kalwani, N. M., Hsiao, S., Sallam, K., Cao, F., … Sandhu, A. T. (2024). Uptake of sodium-glucose cotransporter-2 inhibitors in hospitalized patients with heart failure: insights from the veterans affairs healthcare system. Journal of Cardiac Failure. -
Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study.
Zheng, J., Ambrosy, A. P., Bhatt, A. S., Collins, S. P., Flint, K. M., Fonarow, G. C., … Sandhu, A. T. (2024). Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study. JACC. Heart Failure. -
Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System.
Leung, C. J., Bhatt, A. S., Go, A. S., Parikh, R. V., Garcia, E. A., Le, K. C., … Ambrosy, A. P. (2024). Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System. Journal of Cardiac Failure.
Practice Locations
Heart Failure Clinic at Stanford Stanford, CA
Stanford, CA
Heart Failure Clinic at Stanford
300 Pasteur Drive , 2nd Floor, Room A260
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Heart Failure Clinic in Pleasanton Pleasanton, CA
Pleasanton, CA
Heart Failure Clinic in Pleasanton
5565 W. Las Positas Blvd., Suite 150
Pleasanton , CA 94588
Make An Appointment More Clinic Information » Getting Here »Mechanical Circulatory Support Program Stanford, CA
Stanford, CA
Mechanical Circulatory Support Program
300 Pasteur Drive , 2nd Floor, Room A260
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Heart Transplant Program Stanford, CA
Stanford, CA
Heart Transplant Program
300 Pasteur Drive , 2nd Floor, Room A21
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records